Lilly Vitorovich

Feb 4, 2024 | theaustralian.com.au | Nadine McGrath |CHRISTIAN EDWARDS |David Rogers |Lilly Vitorovich

As the ASX tech index rose in January, it was a stock with its focus firmly on a market beyond our shores that topped the winners’ list. The S&P ASX 200 Info Tech (ASX:XIJ) index was up 1.18 per cent in January, in line with the benchmark S&P ASX 200 (ASX:XJO), which rose 1.19 per cent for the month to finish at a record high of 7680.7 points.

Feb 4, 2024 | theaustralian.com.au | Christian Edwards |David Rogers |Lilly Vitorovich |Joseph Carbone

Celebrating 100 years of making drugs in Denmark last week, the fat-blasting Novo Nordisk dropped some more really big numbers, driven by monstrous sales of its show-stopping diabetes and obesity treatments. The diabetes drugs, which moonlight as apparently effective weight-loss tools (and which helped the Danish giant topple LVMH as Europe’s most valuable company last year), just nudged Novo past the half-a-trillion US dollar valuation.

Dec 22, 2023 | theaustralian.com.au | Will Pavia |Matt Bell |David Rogers |Lilly Vitorovich

Explaining the sleeping arrangements of Queen Elizabeth II and Prince Philip to a royal biographer, her cousin Lady Pamela Hicks said it was customary for upper-class couples to have separate bedrooms. “You don’t want to be bothered with snoring or someone flinging a leg around,” she said. “Then when you are feeling cosy you share your room sometimes.

Nov 29, 2023 | theaustralian.com.au | Eddy Sunarto |Rob Badman |Lilly Vitorovich |Megan Neil

The shares of Imugene (ASX:IMU) rose by as much as 30 per cent on Tuesday after the company’s novel cancer-killing virus, CF33-hNIS (VAXINIA), was granted Fast Track designation by the US FDA. The decision was based on promising data from Imugene’s Phase 1 MAST trial, where low doses of VAXINIA were administered to patients suffering from bile duct cancer. This is a rare disease in which malignant (cancer) cells form in the bile ducts.

Nov 14, 2023 | themercury.com.au | David Rogers |Lilly Vitorovich |Megan Neil |Joseph Carbone

Welcome to the Trading Day blog for Wednesday, November 15. Australian shares are expected to open higher following hefty gains on Wall Street as US inflation slowed more than expected, raising hopes the Federal Reserve is done raising rates for now. The ASX 200 futures index is up 1.2 per cent early Wednesday morning. The Dow Jones Industrial Average is up 1.4 per cent in late US trading, while Nasdaq rallied 2.1 per cent. The S&P 500 jumped 1.8 per cent.